Deaths from breast cancer closer to being numbered as NBCF maps the road to zero deaths by 2030August 21st, 2018
NBCF funds a future for women with bold brand makeover
Australia – 26 July 2018: A future where a breast cancer diagnosis is no longer fatal for anyone is moving closer and closer, with the National Breast Cancer Foundation (NBCF) mapping its journey to achieve zero deaths from breast cancer by 2030. Today, despite the advances made in research so far, there are still 8 deaths from the disease each day[i], highlighting the scale of the task still at hand. With incidence increasing, breast cancer is now the most commonly diagnosed cancer in Australia.[ii] To further strengthen this commitment and mark the next chapter in its mission, NBCF has rebranded with a bold new look.
NBCF’s brand makeover is centred around a mission to ‘Fund A Future For Women’ by looking ahead to a future of improved detection and treatment for the staggering 1 in 8 Australians who are diagnosed with breast cancer in their lifetime[iii], equating to 50 women facing a diagnosis each and every day in Australia.[iv]
In the 25 years since NBCF’s inception, breast cancer survival rates have increased from 76% to 90%[v] however NBCF’s ultimate mission is to completely eradicate any deaths from the disease by targeting the remaining 10% over the next 12 years.
A foundational element of NBCF’s road to 2030 is due, in part, to huge advancements in technology and practices. This includes big data and enhanced analysis techniques. This has led to breast cancer research accelerating at a rapid rate, speeding up the time for researchers to make significant breakthroughs.
To safeguard NBCF’s 2030 mission, it has as adopted a multifaceted approach:
- Targeting the High-Risk: To directly target the last 10% of deaths from breast cancer over the next 12 years, NBCF will identify the major features of women in this group through its Commissioned Research project. In collaboration with the University of South Australia, the project will investigate datasets from across the country to determine how factors such as location demographics or socioeconomic conditions impact survival outcomes. Essentially, this will determine who these 10% are, and why they might not be surviving to fund future research in identified priority areas.
- Health Service Delivery Advancements: As a next step from this research we want to ensure we can facilitate access to better diagnosis and treatments options and help increase health service delivery to those who need it most.
- Tackling Aggressive Breast Cancer Subtypes: Improving the detection and treatment of metastatic and triple negative breast cancers through ground breaking research, particularly in areas such as immunotherapy, is a core focus. These subtypes of breast cancer are generally more aggressive and have lower survival rates than early stage breast cancers, currently accounting for the vast majority of the 10% who don’t survive.
The overall impact of these strategies will be to enable faster diagnoses and more effective treatments for patients – the cornerstone of the NBCF’s road to 2030.
NBCF funded researcher Professor Ricardo Dolcetti, University of Queensland, Diamantina Institute, who is developing a new method of personalised immunotherapy to treat breast cancer, believes this road to 2030 is a significant goalpost.
“If we consider the speed and the advances in terms of cancer research, the evolution that we are living today, I think it is an important goal. Every day we have a new drug approved and we have big successes in the treatment of cancer patients,” he said.
NBCF Speaker Barbe Dolan, who features in NBCF’s rebrand campaign and was diagnosed with breast cancer in 2002, said that NBCF’s zero deaths vision is an exciting yet critical goal.
“Since the time I was first diagnosed there has been so much progress in breast cancer research. I’m passionate about supporting NBCF because I don’t want my daughter to go through what I did. I’d like to think that maybe in a couple of generations it will just like having a common cold that you can treat and get over quickly,” she said.
NBCF Chief Executive Officer Professor Sarah Hosking said that the rebrand is a natural next step for NBCF to highlight its dedication to reaching zero deaths: “With our bold new brand look and feel, we want all women in Australia, regardless of whether have been directly affected by breast cancer or not, to feel empowered and assured that we are doing everything we can through our research, to make a future where they don’t have to live in fear of deaths from breast cancer.
“Every day, researchers, supported by NBCF grants, are making inroads to new prevention, diagnosis and treatment options. Together, we will detect tumours earlier, improve outcomes and ultimately, save lives.”
NBCF can only fund this life changing research with the help of the Australian community. It takes on average between 10-17 years for a research breakthrough to make it into clinic and with only 12 years to 2030, we need to act now. NBCF is appealing to people across Australia to get involved and join the movement towards zero deaths by 2030: https://nbcf.org.au/donate